Comparison between the triglycerides standardization of routine methods used in Japan and the chromotropic acid reference measurement procedure used by the CDC Lipid Standardization Programme
Masakazu Nakamura, Yoshihiro Miyamoto(Asahikawa City Hospital), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Akihiko Kitamura(Osaka Prefectural Medical Center), Michikazu Nakai(National Cerebral and Cardiovascular Center), Hubert W. Vesper(National Center for Environmental Health), Hironori Imano(Kindai University), Hiroyasu Iso(National Center for Global Health and Medicine), Shinichi Sato(Osaka Prefectural Medical Center), Tamio Teramoto(Institute for Atherosclerosis Research), Hiroyuki Noda(Yamagata University), Masahiko Kiyama(University of Medicine Tirana), Kazumasa Yamagishi(University of Tsukuba)
Annals of Clinical Biochemistry International Journal of Laboratory Medicine
December 17, 2015
Cited by 26
Related Papers
Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis
|The Lancet|2012|1.4k
World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
|The Lancet Global Health|2019|1.2k
Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data
|The Lancet Diabetes & Endocrinology|2015|897
Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017
|Journal of Atherosclerosis and Thrombosis|2018|821
What has made the population of Japan healthy?
|The Lancet|2011|677